Company intelligence / Profile preview
Ferrer
Barcelona, Barcelona, Spainferrer.com ↗
- Ownership
- Private
- Employees
- ~1900
- Development stage
- Other
01
Overview
Ferrer has a broad portfolio of prescription drugs—mainly for hospital use—and self-care products. The company focuses on innovative therapies for severe illnesses in pulmonary vascular/interstitial lung disease and neurology. It has a strong R&D pipeline with both proprietary developments and licensed-in assets. Clinical results are not detailed in public sources but the company maintains over 80 clinical trials across its programs. In 2025 it was recognized as the highest-performing pharmaceutical company globally for social/environmental impact by B Corp standards.
- Therapeutic areas
- GastroenterologyPulmonologyPsychiatryCardiovascularDermatologyNeurology
- Modalities
- Small molecules (APIs and finished dosage forms)biologics (limited)food supplementsdiagnostics
- Industry
- Biotech
02
Drug pipeline
23 assets22 more assets in the full pipeline.
03
Partnerships
Joint ventures/partnerships in San Francisco (US), Seoul (South Korea), Berlin (Germany) and Buenos Aires (Argentina)collaborations with academic institutions via EUREKA program participationlicensing partnerships not fully disclosed but likely present given international reach
Beyond the preview
Go deeper on Ferrer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferrer.